Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- German Cancer Research Center in the Helmholtz Association (DKFZ)
- Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V.
- CNRS
- SciLifeLab
- Academic Europe
- Curtin University
- GSI Helmholtzzentrum für Schwerionenforschung
- Hannover Medical School •
- Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
- Institute for bioengineering of Catalonia, IBEC
- International Centre for Translational Eye Research / Institute of Physical Chemistry, Polish Academy of Sciences
- Queensland University of Technology
- The University of Iowa
- University of Bergen
- University of Warwick
- Łukasiewicz Research Network - Krakow Institute of Technology
- AITHYRA GmbH - Research Institute for Biomedical Artificial Intelligence of the Austrian Academy of Sciences
- Aalborg University
- Adelaide University
- Aragon Nanoscience and Materials Institute (INMA) / CSIC-University of Zaragoza
- Delft University of Technology (TU Delft)
- Duke University
- ETH Zürich
- Fundacio de Recerca Clinic Barcelona-Institut d'Investigacions Biomediques August Pi i Sunyer
- Fundació Hospital Universitari Vall d'Hebron- Institut de recerca
- Hector Fellow Academy
- INSERM
- Institute for Ophthalmic Research
- Institute of Biochemistry and Biophysics Polish Academy of Sciences
- Institute of Neuroscience and physiology, Sahlgrenska Academy, university of Gothenburg
- Julius-Maximilians-Universität Würzburg •
- KNAW
- KU LEUVEN
- Karl Landsteiner University of Health Sciences
- Karolinska Institutet, doctoral positions
- Linköping University
- Lunds universitet
- Maastricht University (UM)
- Monash University
- Mossakowski Medical Research Institute, Polish Academy of Sciences
- Purdue University
- Technical University of Munich
- The Ohio State University
- Umeå University
- University of Amsterdam (UvA)
- University of Antwerp
- University of Cambridge
- University of Copenhagen
- University of Florida
- University of Gdansk
- University of Hamburg •
- University of Lund
- University of Mainz
- University of Oldenburg •
- University of Oslo
- University of Potsdam •
- University of Utah
- University of Warwick;
- Utrecht University
- Wageningen University & Research
- 50 more »
- « less
-
Field
-
of researchers with complementary expertise in molecular biology, oncology, medical radiation physics, radionuclide therapy, radiochemistry, magnetic resonance imaging (MRI), radiation dosimetry, and image
-
Leibniz-Institut für Analytische Wissenschaften – ISAS – e.V. | Dortmund, Nordrhein Westfalen | Germany | about 21 hours ago
diagnosis, and therapy of diseases like cardiovascular diseases or cancer. Overall, the institute strives to advance precision medicine by combining knowledge from different fields such as biology, chemistry
-
19 Sep 2026 Job Information Organisation/Company CNRS Department PHysicochimie des Electrolytes et Nanosystèmes InterfaciauX Research Field Chemistry Physics » Chemical physics Physics » Biophysics
-
physics, radionuclide therapy, radiochemistry, magnetic resonance imaging (MRI), radiation dosimetry, and image analysis. We offer Lund University is a public authority, which means that employees get
-
(or equivalent) and eligibility for enrollment in a doctoral school Selection process Candidates should send a curriculum vitae, a motivation letter, academic transcripts (Master 1 and Master 2, if available), a
-
research covers a wide range of topics from radiobiology, radiation physics and space research to radiation therapy. The Particle “Therapy Physics” sub-group of the Biophysics department is dedicated
-
therapies against glioblastoma. The PhD project will be conducted within the framework of the project Glioblastoma Blood-Brain Barrier Integrated Model for T-Cell Therapies (GBBRAIN-T). This fellowship is
-
industrial research environments. Project Aims: Targeted radionuclide therapy is an emerging and highly promising approach for cancer treatment. Radioconjugates combine tumour-targeting molecules with
-
machine learning and AI methods to develop clinical decision support systems for high-flow nasal cannula therapy. The project: Concerns around the possible negative consequences of delayed escalation
-
more than 50% of breast cancer cases. Current treatment strategies involve chemotherapy, endocrine therapy and, subsequently, targeted therapies. However, treatment resistance frequently develops, while